Dr. Akbar Niazi Teaching Hospital (ANTH) has been granted a license by the Drug Regulatory Authority of Pakistan (DRAP) to serve as a Clinical Trial Site for phase three and four clinical trials.

DRAP’s CEO Asim Rauf presented the license to Yasir Khan Niazi, the CEO of ANTH.

Chairman ANTH Dr. Ghulam Akbar Khan Niazi was presented with the license in an impressive ceremony in the presence of the Advisor to the Chairman Prof. Dr. Khalid Hasan, Director Col. (R) Dr. Ghulam Mujtaba Abbasi, CFO Hasan Ali Khan, the CEO and other officials.

ANTH has gained approval as a Clinical Trials Site after successfully meeting DRAP's criteria and the hospital is all set to initiate clinical trials to provide essential data on the safety and efficacy of new medical interventions, ultimately improving the healthcare delivery.

Source: Radio Pakistan